Spit test may predict your best weight loss drug
NCT ID NCT06814938
Summary
This study is testing if a simple saliva test can identify which people with obesity are most likely to respond well to the weight loss medication semaglutide. Researchers will compare weight loss in people who test positive or negative on the saliva test while taking the drug or a placebo. The goal is to create a more personalized, effective treatment plan for obesity.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic in Florida
RECRUITINGJacksonville, Florida, 32224, United States
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.